Shanghai OPM Biosciences Balance Sheet Health
Financial Health criteria checks 6/6
Shanghai OPM Biosciences has a total shareholder equity of CN¥2.1B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥2.3B and CN¥158.0M respectively. Shanghai OPM Biosciences's EBIT is CN¥12.9M making its interest coverage ratio -0.4. It has cash and short-term investments of CN¥1.4B.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | -0.4x |
| Cash | CN¥1.38b |
| Equity | CN¥2.10b |
| Total liabilities | CN¥158.04m |
| Total assets | CN¥2.26b |
Recent financial health updates
No updates
Recent updates
After Leaping 47% Shanghai OPM Biosciences Co., Ltd. (SHSE:688293) Shares Are Not Flying Under The Radar
Nov 21
Weak Statutory Earnings May Not Tell The Whole Story For Shanghai OPM Biosciences (SHSE:688293)
Nov 07Shanghai OPM Biosciences' (SHSE:688293) Weak Earnings May Only Reveal A Part Of The Whole Picture
May 06Optimistic Investors Push Shanghai OPM Biosciences Co., Ltd. (SHSE:688293) Shares Up 28% But Growth Is Lacking
Mar 04Financial Position Analysis
Short Term Liabilities: 688293's short term assets (CN¥1.6B) exceed its short term liabilities (CN¥88.9M).
Long Term Liabilities: 688293's short term assets (CN¥1.6B) exceed its long term liabilities (CN¥69.1M).
Debt to Equity History and Analysis
Debt Level: 688293 is debt free.
Reducing Debt: 688293 has no debt compared to 5 years ago when its debt to equity ratio was 45.9%.
Debt Coverage: 688293 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 688293 has no debt, therefore coverage of interest payments is not a concern.